Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1000416-51-2

C26H19F3N6O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1000416-51-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1000416-51-2 Structure

  • Basic information

    1. Product Name: C26H19F3N6O2S
    2. Synonyms:
    3. CAS NO:1000416-51-2
    4. Molecular Formula:
    5. Molecular Weight: 536.537
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1000416-51-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C26H19F3N6O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C26H19F3N6O2S(1000416-51-2)
    11. EPA Substance Registry System: C26H19F3N6O2S(1000416-51-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1000416-51-2(Hazardous Substances Data)

1000416-51-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1000416-51-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,4,1 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1000416-51:
(9*1)+(8*0)+(7*0)+(6*0)+(5*4)+(4*1)+(3*6)+(2*5)+(1*1)=62
62 % 10 = 2
So 1000416-51-2 is a valid CAS Registry Number.

1000416-51-2Downstream Products

1000416-51-2Relevant articles and documents

Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility

Wang, Xianghong,Chakrabarti, Partha P.,Ognyanov, Vassil I.,Pettus, Liping H.,Tamir, Rami,Tan, Helming,Tang, Phi,Treanor, James J.S.,Gavva, Narender R.,Norman, Mark H.

, p. 6539 - 6545 (2008/09/20)

A series of trisubstituted pyrimidines were synthesized to improve aqueous solubility of our first TRPV1 clinical candidate (1; AMG 517), while maintaining potent TRPV1 inhibitory activity. Structure-activity and structure-solubility studies led to the id

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1000416-51-2